The Associated Press is reporting on a study in the New England Journal of Medicine (NEJM) which finds that Pfizer seriously misrepresented drug trial results related to their epilepsy drug Neurontin.
You can find a more complete report of both the NEJM article and the AP piece at Udo Schüklenk’s blog.
It’s been a bad stretch for Pfizer. The company recently agreed to pay $430 million in criminal fines and civil penalties for promoting Neurontin for “off-label” uses it was not approved for.
Paper Trail: I got this from Udo Schüklenk’s blog, and he got it from the AP, who got it from NEJM, who got it from…
(+2 rating, 2 votes)
Loading ...
Twitter Updates
This website uses IntenseDebate comments, but they are not currently loaded because either your browser doesn't support JavaScript, or they didn't load fast enough.